Yubo International Biotech Limited
YBGJOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$1006454
P/E Ratio—
52W High$0.1776
52W Low$0.0079
Yubo International Biotech Limited (YBGJ) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · YBGJ · as of 2026-06-15
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.01M | $0.01M | $0.02M | $0.03M | $1.38M |
| Net Receivables | $0.43M | $0.44M | $0.35M | $0.56M | $0.43M |
| Inventory | $0.02M | $0.04M | $0.32M | $0.16M | $0.07M |
| Total Current Assets | $0.67M | $0.68M | $0.75M | $1.06M | $1.91M |
| PP&E Net | $0.12M | $0.68M | $1.41M | $3.34M | $0.39M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.04M | $0.05M | $0.07M | $0.04M | $0.05M |
| Total Assets | $0.85M | $1.53M | $2.35M | $4.59M | $2.44M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.37M | $0.40M | $0.77M | $0.32M |
| Accounts Payable | $1.06M | $1.04M | $0.55M | $0.28M | $0.10M |
| Total Current Liabilities | $2.79M | $4.72M | $2.52M | $2.79M | $1.28M |
| Long-Term Debt | $0.00M | $0.00M | $0.39M | $1.93M | $0.00M |
| Total Liabilities | $2.79M | $4.83M | $2.91M | $4.72M | $1.28M |
| Stockholders Equity | |||||
| Retained Earnings | ($7.74M) | ($6.66M) | ($3.69M) | ($2.49M) | ($0.94M) |
| Total Stockholders Equity | ($1.95M) | ($3.42M) | ($0.57M) | ($0.13M) | $1.17M |
| Total Liab & Equity(computed) | $0.84M | $1.41M | $2.35M | $4.59M | $2.44M |
| Debt Summary | |||||
| Total Debt | $0.08M | $0.48M | $0.79M | $2.69M | $0.32M |
| Net Debt | $0.07M | $0.47M | $0.77M | $2.67M | ($1.07M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · USD · M
Explore more Yubo International Biotech Limited data
About Yubo International Biotech Limited (YBGJ) Balance Sheet
Yubo International Biotech Limited (YBGJ) balance sheet shows total assets of $0.00B with cash of $0.00B. Total liabilities are $0.00B, total debt $0.00B, and stockholders equity ($0.00B).
Frequently asked questions
YBGJ · 4 questionsYubo International Biotech Limited has total debt of $0.00B with net debt of $0.00B.
YBGJ total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15